Authors:
BARNETT ML
KREMER JM
STCLAIR EW
CLEGG DO
FURST D
WEISMAN M
FLETCHER MJF
CHASANTABER S
FINGER E
MORALES A
LE CH
TRENTHAM DE
Citation: Ml. Barnett et al., TREATMENT OF RHEUMATOID-ARTHRITIS WITH ORAL TYPE-II COLLAGEN - RESULTS OF A MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL, Arthritis and rheumatism, 41(2), 1998, pp. 290-297
Authors:
BLUHM GB
SHARP JT
TILLEY BC
ALARCON GS
COOPER SM
PILLEMER SR
CLEGG DO
HEYSE SP
TRENTHAM DE
NEUNER R
KAPLAN DA
LEISEN JCC
BUCKLEY L
DUNCAN H
TUTTLEMAN M
LI SH
FOWLER SE
Citation: Gb. Bluhm et al., RADIOGRAPHIC RESULTS FROM THE MINOCYCLINE IN RHEUMATOID-ARTHRITIS (MIRA) TRIAL, Journal of rheumatology, 24(7), 1997, pp. 1295-1302
Authors:
TUTTLEMAN M
PILLEMER SR
TILLEY BC
FOWLER SE
BUCKLEY LM
ALARCON GS
TRENTHAM DE
NEUNER R
CLEGG DO
LEISEN JCC
HEYSE SP
Citation: M. Tuttleman et al., A CROSS-SECTIONAL ASSESSMENT OF HEALTH-STATUS INSTRUMENTS IN PATIENTSWITH RHEUMATOID-ARTHRITIS PARTICIPATING IN A CLINICAL-TRIAL, Journal of rheumatology, 24(10), 1997, pp. 1910-1915
Authors:
PILLEMER SR
FOWLER SE
TILLEY BC
ALARCON GS
HEYSE SP
TRENTHAM DE
NEUNER R
CLEGG DO
LEISEN JCC
COOPER SM
DUNCAN H
TUTTLEMAN M
Citation: Sr. Pillemer et al., MEANINGFUL IMPROVEMENT CRITERIA SETS IN A RHEUMATOID-ARTHRITIS CLINICAL-TRIAL, Arthritis and rheumatism, 40(3), 1997, pp. 419-425
Citation: Ml. Barnett et De. Trentham, TREATMENT OF JUVENILE RHEUMATOID-ARTHRITIS WITH ORAL TYPE-II COLLAGEN- REPLY, Arthritis and rheumatism, 40(2), 1997, pp. 392-393
Authors:
SEWELL KL
BREEDVELD F
FURRIE E
OBRIEN J
BRINCKERHOFF C
DYNESIUSTRENTHAM R
NOSAKA Y
TRENTHAM DE
Citation: Kl. Sewell et al., THE EFFECT OF MINOCYCLINE IN RAT MODELS OF INFLAMMATORY ARTHRITIS - CORRELATION OF ARTHRITIS SUPPRESSION WITH ENHANCED T-CELL CALCIUM FLUX, Cellular immunology, 167(2), 1996, pp. 195-204
Citation: Ml. Barnett et al., A PILOT TRIAL OF ORAL TYPE-II COLLAGEN IN THE TREATMENT OF JUVENILE RHEUMATOID-ARTHRITIS, Arthritis and rheumatism, 39(4), 1996, pp. 623-628
Authors:
REVEILLE JD
ALARCON GS
FOWLER SE
PILLEMER SR
NEUNER R
CLEGG DO
MIKHAIL IS
TRENTHAM DE
LEISEN JCC
BLUHM G
COOPER SM
DUNCAN H
TUTTLEMAN M
HEYSE SP
SHARP JT
TILLEY B
Citation: Jd. Reveille et al., HLA-DRB1 GENES AND DISEASE SEVERITY IN RHEUMATOID-ARTHRITIS, Arthritis and rheumatism, 39(11), 1996, pp. 1802-1807
Citation: De. Trentham et Ra. Dynesiustrentham, ANTIBIOTIC-THERAPY FOR RHEUMATOID-ARTHRITIS - SCIENTIFIC AND ANECDOTAL APPRAISALS, Rheumatic diseases clinics of North America, 21(3), 1995, pp. 817-834
Authors:
MORELAND LW
SEWELL KL
TRENTHAM DE
BUCY RP
SULLIVAN WF
SCHROHENLOHER RE
SHMERLING RH
PARKER KC
SWARTZ WG
WOODWORTH TG
KOOPMAN WJ
Citation: Lw. Moreland et al., INTERLEUKIN-2 DIPHTHERIA FUSION PROTEIN (DAB(486)IL-2) IN REFRACTORY RHEUMATOID-ARTHRITIS - A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL WITH OPEN-LABEL EXTENSION, Arthritis and rheumatism, 38(9), 1995, pp. 1177-1186
Authors:
TILLEY BC
ALARCON GS
HEYSE SP
TRENTHAM DE
NEUNER R
KAPLAN DA
CLEGG DO
LEISEN JCC
BUCKLEY L
COOPER SM
DUNCAN H
PILLEMER SR
TUTTLEMAN M
FOWLER SE
Citation: Bc. Tilley et al., MINOCYCLINE IN RHEUMATOID-ARTHRITIS - A 48-WEEK, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL, Annals of internal medicine, 122(2), 1995, pp. 81-89
Authors:
WEINER HL
FRIEDMAN A
MILLER A
KHOURY SJ
ALSABBAGH A
SANTOS L
SAYEGH M
NUSSENBLATT RB
TRENTHAM DE
HAFLER DA
Citation: Hl. Weiner et al., ORAL TOLERANCE - IMMUNOLOGICAL MECHANISMS AND TREATMENT OF ANIMAL ANDHUMAN ORGAN-SPECIFIC AUTOIMMUNE-DISEASES BY ORAL-ADMINISTRATION OF AUTOANTIGENS, Annual review of immunology, 12, 1994, pp. 809-837
Authors:
MORELAND LW
SEWELL KL
SULLIVAN WF
SHMERLING RH
PARKER KC
SWARTZ WG
WOODWORTH TG
TRENTHAM DE
KOOPMAN WJ
Citation: Lw. Moreland et al., DOUBLE-BLIND PLACEBO-CONTROLLED PHASE-II TRIAL OF DIPHTHERIA-INTERLEUKIN-2 FUSION TOXIN (DAB486IL-2) IN PATIENTS WITH REFRACTORY RHEUMATOID-ARTHRITIS (RA), Arthritis and rheumatism, 36(9), 1993, pp. 190000039-190000039
Citation: Mj. Kafina et De. Trentham, ANALYSIS OF CAMPTOTHECIN AND TOPOTECAN ENZYME-INHIBITION OF DNA TOPOISOMERASE IN SCLERODERMA BY KINETICS AND SKIN THICKNESS IN A MOUSE MODEL, Arthritis and rheumatism, 36(9), 1993, pp. 190000272-190000272
Citation: Lw. Moreland et al., TREATMENT OF REFRACTORY RHEUMATOID-ARTHRITIS WITH DAB(486)IL-2 FUSIONTOXIN - DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY, Arthritis and rheumatism, 36(5), 1993, pp. 24-24
Authors:
SEWELL KL
MORELAND LW
SULLIVAN WF
SHMERLING RH
PARKER KC
SWARTZ WG
WOODWORTH TG
KOOPMAN WJ
TRENTHAM DE
Citation: Kl. Sewell et al., DAB(486)IL-2 IN RHEUMATOID-ARTHRITIS - A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL WITH OPEN-LABEL CONTINUATION, Arthritis and rheumatism, 36(5), 1993, pp. 31-31